XML 26 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity and Stock-Based Compensation
6 Months Ended
Jun. 27, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stockholder' Equity and Stock Based Compensation

8. Stockholders’ Equity and Stock-Based Compensation

Stock-Based Compensation

The Company accounts for stock-based compensation granted to employees and directors, including employees stock option awards, restricted stock and restricted stock units in accordance with ASC 718, “Compensation – Stock Compensation” (“ASC 718”). Accordingly, stock-based compensation cost is measured at grant date, based on the fair value of the award, and is recognized as expense over the employee’s service period. The Company recognizes compensation expense on a ratable basis over the requisite service period of the award.

The Company values options using the Black-Scholes option pricing model. Time-based restricted stock units (“RSUs”) are valued at the grant date fair value of the underlying common shares. Performance-based RSUs without market conditions are valued at grant date fair value of the underlying common shares. Performance-based RSUs granted with market conditions and performance-based stock options with market conditions are valued using the Monte Carlo simulation model. The Black-Scholes option pricing model requires the use of highly subjective and complex assumptions which determine the fair value of stock-based awards, including the option’s expected term and the price volatility of the underlying stock. The Monte Carlo simulation model incorporates assumptions for the holding period, risk-free interest rate, stock price volatility and dividend yield.

2008 Equity Incentive Plan.

The terms of awards granted during the six months ended June 27, 2020 were consistent with those described in the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 28, 2019.

The following table shows stock-based compensation expenses included in the condensed consolidated statements of operations for the three and six months ended June 27, 2020 and June 29, 2019:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

(in thousands)

 

June 27, 2020

 

 

June 29, 2019

 

 

June 27, 2020

 

 

June 29, 2019

 

Cost of revenues

 

$

35

 

 

$

10

 

 

$

59

 

 

$

29

 

Research and development

 

 

24

 

 

 

62

 

 

 

(7

)

 

 

165

 

Sales and marketing

 

 

134

 

 

 

46

 

 

 

173

 

 

 

209

 

General and administrative

 

 

243

 

 

 

507

 

 

 

306

 

 

 

837

 

 

 

$

436

 

 

$

625

 

 

$

531

 

 

$

1,240

 

 

Stock-based compensation expense capitalized to inventory was immaterial for the six months ended June 27, 2020 and June 29, 2019.

Occasionally, the Company will grant stock-based instruments to non-employees. During the six months ended June 27, 2020 and June 29, 2019, the amount of stock-based compensation related to non-employee options and RSUs was not material.

As of June 27, 2020, there was $2.5 million of total unrecognized compensation cost, net of expected forfeitures, related to non-vested stock-based compensation arrangements. The cost is expected to be recognized over a weighted average period of 2.3 years.  

Summary of Stock Options.

The following table summarizes stock options information during the six months ended June 27, 2020:

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

Per Share

 

 

Aggregate

Intrinsic

Value

(thousands)

 

Outstanding as of December 28, 2019

 

 

1,383,552

 

 

$

6.11

 

 

 

 

 

Granted

 

 

78,500

 

 

$

2.15

 

 

 

 

 

Exercised

 

 

 

 

$

 

 

 

 

 

Canceled or forfeited

 

 

(185,388

)

 

$

6.95

 

 

 

 

 

Outstanding as of June 27, 2020

 

 

1,276,664

 

 

$

5.74

 

 

$

4

 

 

The weighted average grant date fair value of the options granted was $1.01 and $1.93 per share for the six months ended June 27, 2020 and June 29, 2019, respectively.

The Company uses the Black-Scholes option-pricing model to estimate the fair value of stock-based awards (options) with the following weighted average assumptions:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 27, 2020

 

 

June 29, 2019

 

 

June 27, 2020

 

 

June 29, 2019

 

Average risk free interest rate

 

 

0.27

%

 

 

1.74

%

 

 

0.39

%

 

 

1.76

%

Expected life (in years)

 

4.55 years

 

 

4.55 years

 

 

4.55 years

 

 

4.55 years

 

Dividend yield

 

 

%

 

 

%

 

 

%

 

 

%

Average volatility

 

 

62

%

 

 

45

%

 

 

59

%

 

 

45

%

 

Performance stock options granted with market conditions are valued using a Monte Carlo simulation model in combination with a Black-Scholes option pricing model.

Option-pricing models require the input of various subjective assumptions, including the option’s expected life and the price volatility of the underlying stock. The expected stock price volatility is based on analysis of the Company’s stock price history over a period commensurate with the expected term of the options, trading volume of the Company’s stock, look-back volatilities and Company-specific events that affected volatility in a prior period. The expected term of employee stock options represents the weighted average period the stock options are expected to remain outstanding and is based on the history of exercises and cancellations on all past option grants made by the Company, the contractual term, the vesting period and the expected remaining term of the outstanding options. The risk-free interest rate is based on the U.S. Treasury interest rates whose term is consistent with the expected life of the stock options. No dividend yield is included as the Company has not issued any dividends and does not anticipate issuing any dividends in the future.

Information regarding stock options outstanding, vested, expected to vest, and exercisable as of June 27, 2020 is summarized below:

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

 

 

Weighted

Average

Remaining

Contractual

Life (Years)

 

 

Aggregate

Intrinsic Value

(thousands)

 

Options outstanding

 

 

1,276,664

 

 

$

5.74

 

 

 

5.07

 

 

$

4

 

Options vested and expected to vest

 

 

1,127,406

 

 

$

5.92

 

 

 

4.95

 

 

$

3

 

Options exercisable

 

 

515,816

 

 

$

7.42

 

 

 

3.86

 

 

$

 

 

The aggregate intrinsic value in the table above represents the pre-tax intrinsic value, based on the Company’s closing price as of June 27, 2020, that would have been received by option holders had all option holders exercised their stock options as of that date. This amount changes based on the fair market value of the Company’s common stock. The total intrinsic value of options exercised for the six months ended June 27, 2020 and June 29, 2019 was approximately $0 thousand.  

Summary of Restricted Stock Units and Awards

Information regarding the restricted stock units (“RSUs”) activity for the six months ended June 27, 2020 is summarized below:

 

 

 

Number

of Shares

 

Outstanding as of December 28, 2019

 

 

411,133

 

Restricted stock units granted

 

 

276,327

 

Restricted stock units released

 

 

(73,652

)

Restricted stock units forfeited

 

 

(103,785

)

Outstanding as of June 27, 2020

 

 

510,023